Outsourcing Pharma
MARCH 3, 2021
The 2020 Pfizer/BioNTech COVID-19 vaccine trial recruited more than 44,000 participants and reached submission for emergency authorization in 248 days: showing unprecedented speed and agility in the context of a global pandemic. So what have been the learnings from the trial â and how could they be applied to vaccine development in the future?
pharmaphorum
MARCH 2, 2021
Zebra Technologies healthcare lead Chris Sullivan discusses the COVID-19 vaccine rollout and how technology can streamline the process to combat new variants. . While the rollout of the COVID-19 vaccine has signified the first signs of light at the end of the tunnel, the reality is that this public health crisis is still far from over. More than 100 million people worldwide have been vaccinated thus far, but several new variants of the virus have emerged in South Africa, Brazil and the United Ki
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Druggist
FEBRUARY 28, 2021
Melatonin is a hormone that is released at night by the pineal gland located in the brain. Melatonin controls the sleep-wake cycle (24-hour cycle). In other words, melatonin acts as a biological clock that regulates sleep. Melatonin, therefore, can be used to promote and regulate sleep (Wagner et al., 1998). This post answers the question: Can you get melatonin over the counter in the UK?
Pharma Marketing Network
MARCH 1, 2021
[link]. Blockchain technology has become an increasing tool for life science organizations. How is this technology being implemented, and what value does it offer? Join Darshan Kulkarni as he talks with guest Jim Nasr about the function of blockchain, and how distributed ledger technologies such as blockchain are making an impact on healthcare. The post DarshanTalks: Blockchain & Information Technology</br> – March 1, 2021 appeared first on Pharma Marketing Network.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Outsourcing Pharma
MARCH 2, 2021
According to Noxopharm, a recent study shows combining its Veyonda drug and a radiopharmaceutical yields favorable results against prostate cancer.
pharmaphorum
MARCH 2, 2021
Clinical trial software facilitates clinical trials from conception to finish. For example protocol management, CRF design , metadata management, and the collection, analysis, and submission of compliant clinical study data to regulatory authorities. The aim is to get quality clinical products to the market faster. Traditionally spreadsheets have been used to record and manage all the various aspects of clinical trials.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Marketing Network
MARCH 3, 2021
We’ve talked before about how COVID-19 has upended our personal and business lives, and how the pharma industry was able to – impressively – shift gears to meet the challenges the pandemic brought. But what about patients? And what about the disrupted patient journey? What can our industry do to ensure patients maintain continuity of care at a time when good health is imperative?
Outsourcing Pharma
MARCH 1, 2021
A leader from the genetic solutions firm explains how genetic testing and counseling can help trial teams form more beneficial connections with patients.
pharmaphorum
MARCH 4, 2021
AI can be transformative for all areas of healthcare, but often these systems are built off biased datasets that don’t reflect the true diversity of the general public – leading to approaches that only work for specific populations. Intouch Group’s Abid Rahman explains this concept of AI equity and gives some practical tips for how companies can work towards it.
Pharma Times
MARCH 1, 2021
Latest funding round includes investments from Foresite Capital and F-Prime Capital
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Marketing Network
MARCH 3, 2021
We’ve talked before about how COVID-19 has upended our personal and business lives, and how the pharma industry was able to – impressively – shift gears to meet the challenges the pandemic brought. But what about patients? And what about the disrupted patient journey? What can our industry do to ensure patients maintain continuity of care at a time when good health is imperative?
Outsourcing Pharma
MARCH 4, 2021
The CRO will receive funding to fuel a five-year Research Project Award, with the goal to design and conduct research of potential PTSD treatment options.
pharmaphorum
MARCH 4, 2021
UK chancellor Rishi Sunak has announced a budget loaded with initiatives designed to kick-start the UK’s economy as it recovers from the coronavirus pandemic, with vaccine development, pharma and life sciences playing a key role. The ongoing fight against COVID-19 was a top-line feature of the budget announcement, with an extra £1.65bn to ensure the vaccination roll-out continues to be a success.
Pharma Mirror
MARCH 2, 2021
Eisai Co., Ltd. announced that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has obtained approval for the in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. This approval is the first approval for DAYVIGO in Asia outside of Japan.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
BuzzRx
MARCH 1, 2021
Melatonin is a hormone naturally produced by the central nervous system in the pineal gland, which is located in the brain. Melatonin release is correlated with the time of day. For example, melatonin levels are lowest during the day and peak during the evening when it is dark. Melatonin secretion regulates the body’s circadian rhythms while synchronizing the sleep-wake cycle throughout the day.
Outsourcing Pharma
MARCH 2, 2021
The Verisense Pulse+ can measure heart rate, oxygen saturation, emotional responses, and activity and sleep levels of at-home clinical trial participants.
pharmaphorum
MARCH 1, 2021
European regulators have refused to back GlaxoSmithKline’s daily triple therapy Trelegy Ellipta for asthma, denying a label extension because there was no evidence to show a reduction of flare-ups. It’s a blow for GSK, which hopes that Trelegy (fluticasone furoate+umeclidinium+vilanterol) will help to revive the fortunes of its respiratory diseases franchise.
Pharma Mirror
MARCH 2, 2021
I Holland, leaders in the manufacture of tablet tooling for the pharmaceutical and nutraceutical markets, has announced a series of appointments to form a new senior management team to lead the company moving forward. The new Board of Directors consists of six highly-experienced team members many of which remain from the previous management team. David Hinds has handed over the baton of Managing Director to Javier Raposo but will continue to serve on the Board as Non-Executive Director.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
MARCH 5, 2021
Tirzepatide demonstrated superior A1C and body weight reduction in type 2 diabetes
Outsourcing Pharma
MARCH 4, 2021
The companies announcing acquisitions, new hires, promotions and other news this month include Syneos, Elligo, PCI Pharma Services, I Holland and more.
pharmaphorum
MARCH 2, 2021
Syneos Health Communications has made several senior hires to strengthen its Europe-based team. A portfolio of Syneos Health agencies, Syneos Health Communications, offers expertise spanning advertising and branding, public relations and medical communications. Orrin Pollard. Among the most notable hires is Orrin Pollard, who joins as director of European creative expression.
Pharma Mirror
FEBRUARY 28, 2021
Novartis announced the Health Sciences Authority (HSA) has approved* Piqray®, an ?-specific class I phosphatidylinositol-3-kinase (PIK3CA) inhibitor, for the treatment of postmenopausal women, and men, with hormone receptor positive (HR+), human epidermal growth factor receptor 2 (HER2-) negative, advanced breast cancer with a PIK3CA mutation in combination with fulvestrant after disease progression following an endocrine-based regimen.
Pharma Times
MARCH 4, 2021
Collaboration will focus on vaccines for infectious diseases
Outsourcing Pharma
MARCH 2, 2021
A leader from Vocalis Health explains how health data can be culled from patient voice recordings to screen and monitor COVID-19 and other conditions.
pharmaphorum
MARCH 5, 2021
In the latest episode of our Health Innovators series, Paul Tunnah speaks to Billy Boyle, co-founder and CEO of Owlstone Medical, one of the UK’s most promising diagnostic startups. The Cambridge, UK-based company is on a mission to save 100,000 lives and $1.5bn in healthcare costs with its breath biopsy platform for early detection of cancer. Owlstone is developing a breath-based analyser that captures Volatile Organic Compounds (VOCs) in breath non-invasively, and analyses them with high sensi
Pharma Mirror
FEBRUARY 28, 2021
NLP and social graphs are effective instruments to speed up investigator recruitment and ensure timely pharmaceutical product releases. Read how NLP can leverage the power of unstructured data and help find doctors-influencers that can substantially provide assistance to a clinical trial. Igor Kruglyak is a Senior Advisor at the global IT service provider Avenga and a 35+ year veteran executive of global key development and deployment projects.
Pharma Times
MARCH 1, 2021
First therapy approved for the ultra-rare and progressive condition
Outsourcing Pharma
MARCH 1, 2021
The company has increased capabilities at its Bend, Oregon location, including its SimpliFiH Solutions first-in-human services for small-molecule drugs.
pharmaphorum
MARCH 5, 2021
The concept of personalised medicine is becoming established in cancer, with an increasing number of drugs targeting specific mutations making it to market. Alec Mian, CEO at diagnostics firm Curelator, spoke to pharmaphorum’s news editor Richard Staines about the company’s plans to apply a similar paradigm to other diseases such as migraine. . There has been noticeable progress in migraine as a disease area in the last few years, with a new class of drugs coming to market that could help preven
Med Ed 101
MARCH 3, 2021
Obesity is a major risk factor for many comorbidities (hypertension, dyslipidemia, osteoarthritis, sleep apnea, heart disease, type 2 diabetes) and increases all-cause and cardiovascular mortality. With over 40% of Americans qualifying as obese (body mass index ?30 kg/m2) in 2017-18 it is no surprise that weight loss remains a hot ticket item today.
Pharma Times
MARCH 5, 2021
University of Strathclyde spin-out is developing liquid biopsies for early cancer detection
Outsourcing Pharma
MARCH 1, 2021
The partnership reportedly will center on optimizing integration for EHR data and remote-source data review to help accelerate clinical research results.
pharmaphorum
MARCH 5, 2021
The European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company illegally delayed launches and use of generic versions of its blockbuster multiple sclerosis drug Copaxone. Copaxone (glatiramer) was once a mainstay of Teva’s portfolio with blockbuster sales that the Israel-based pharma fought hard to protect, including releasing a long-acting version to counter cheaper copycat drugs.
Expert insights. Personalized for you.
136 
Let's personalize your content